Tradestie Institutional Equity Comparison Engine
GERN vs ASTM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GERN Overall Edge
GERN Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Geron Corp (GERN) driven by superior Valuation, Growth & Margin while ASTM counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, GERN trades at 49.5x Forward P/E with -7.2% operating margin (+27.4% YoY revenue) versus ASTM at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, GERN sits in BREAKDOWN (19th %ile IV; Dealer Gamma Walls on Pro) against ASTM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
GERN
GERN 49.5x vs ASTM N/M Fwd P/E
Growth & Margin Winner
GERN
Op Margin -7.2% vs N/A ยท YoY +27.4% vs N/A
Momentum & Technical Winner
ASTM
1Y -19.4% vs +1.1% ยท 52W Pos 3% vs 53%
Options & Structure Winner
ASTM
BREAKDOWN (19th %ile IV) vs UNCLASSIFIED (N/A IV)
GERN
NASDAQ
Geron Corp
Pharmaceutical Preparations
$0.87
-4.63% 1D
Market Cap
$588.2M
1M Return
-22.95%
1Y Return
-19.38%
Forward P/E
49.5x
Unified AI Score
48.4 / 100
HOLD
Tech 40.0
Fund 56.0
Flow 65.0
Mom 64.0
ASTM
US Equity
ASTM
Institutional Equity
$25.29
+0.08% 1D
Market Cap
N/A
1M Return
+0.52%
1Y Return
+1.14%
Forward P/E
N/M
Unified AI Score
50.6 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GERN -19.38%
ASTM +1.14%
Spread: +26.08 pp (ASTM Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GERN TTM Op. Margin: -7.2%
ASTM TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GERN vs ASTM. Trailing 12-month operating profitability (GERN -7.2% vs ASTM N/A) and valuation multiples (GERN 49.5x vs ASTM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GERN | ASTM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $588.2M | N/A | Larger Scale | GERN |
| Trailing P/E Ratio Valuation | 49.5x | N/M | Lower Multiple | GERN |
| Forward P/E Ratio Valuation | 49.5x | N/M | Lower Multiple | GERN |
| Revenue Growth (YoY) Growth | +27.4% | N/A | Higher Growth | GERN |
| Operating Margin (TTM) Profitability | -7.2% | N/A | Higher Margin | GERN |
| Net Profit Margin Profitability | -22.0% | N/A | Higher Margin | GERN |
| Return on Equity (ROE) Capital Efficiency | -20.1% | N/A | Higher ROE | GERN |
| 52-Week Range Position Momentum | 3% ($1โ$2) | 53% ($25โ$26) | Stronger Trend | ASTM |
| Beta / 30D Volatility Risk Regime | 1.48ฮฒ ยท 102% Vol | N/A | Lower Realized Risk | ASTM |
| Unified Institutional Score Composite Signal | 48.4 / 100 (HOLD) | 50.6 / 100 (HOLD) | Higher Composite | ASTM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GERN vs ASTM Buy Guide
GERN
BREAKDOWN
76d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
19th %ile
IV Regime
Compressed (<25th %ile)
ASTM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GERN nor ASTM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.